UK – NICE recommends Elmiron for bladder pain syndrome

The National Institute for Health and Care Excellence (NICE) has recommended Consilient Health’s Elmiron (pentosan polysulfate sodium) for bladder pain syndrome.

The company “welcomed” the decision, saying that the organisation has approved the medicine, usually used in BPS with glomerulations or Hunner’s lesions, is used in accordance with specified considerations.

The drug in question works by passing into the urine and attaches to the lining of the bladder, helping to form a protective layer.

The recommendation comes after Consilient Health agreed a Patient Access Scheme with NICE, in order to make the drug available to the NHS. The deal works on the conditions that the medicine is given for patients whose condition has not responded to an adequate trial of standard oral treatments, and who has not been offered it in combination with bladder instillations…